Home Biosimilar Antibodies Others Others antibody Glembatumumab (Anti-GPNMB) For research use only.
Not for use in humans.

Glembatumumab (Anti-GPNMB)

Synonyms: null

Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. MW: 145.5 KD.

Glembatumumab (Anti-GPNMB)

Purity & Quality Control

Batch: A247501 Purity: 99% Protein concentration: 7.4mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. MW: 145.5 KD.

Product Details

CAS No. 1020264-78-1
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Glembatumumab (Anti-GPNMB) | Glembatumumab (Anti-GPNMB) supplier | purchase Glembatumumab (Anti-GPNMB) | Glembatumumab (Anti-GPNMB) cost | Glembatumumab (Anti-GPNMB) manufacturer | order Glembatumumab (Anti-GPNMB) | Glembatumumab (Anti-GPNMB) distributor